Status: current, Defined. Date: 31-Jul 2014. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1297241000168114 | Neutrogena T/Gel Therapeutic Conditioner (salicylic acid 20 mg / 1 g) conditioner (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1297251000168111 | Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | has intended active ingredient | salicylic acid | true | Inferred relationship | Some | 2057502950 | |
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | has Australian BoSS | salicylic acid | true | Inferred relationship | Some | 2057502950 | |
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | has unit of use | continuous | true | Inferred relationship | Some | 2057502951 | |
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | Is a | Neutrogena T/Gel Therapeutic Conditioner | true | Inferred relationship | Some | ||
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | Is a | salicylic acid 20 mg / 1 g conditioner (medicinal product unit of use) | true | Inferred relationship | Some | ||
Neutrogena T/Gel Therapeutic Conditioner 2% conditioner | has manufactured dose form | conditioner | true | Inferred relationship | Some |
Reference Sets
Trade product unit of use reference set